Related references
Note: Only part of the references are listed.Systems Biological Analysis of Immune Response to Influenza Vaccination
Mario Cortese et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
The structural basis of herpesvirus entry
Sarah A. Connolly et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
P. J. Klasse et al.
SCIENCE ADVANCES (2021)
B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition
Yan Chen et al.
MSPHERE (2021)
The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development
Cong Sun et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
Hui Liu et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse
Yujin Kim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Vaccination against the Epstein-Barr virus
Julia Ruhl et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
MYC Controls the Epstein-Barr Virus Lytic Switch
Rui Guo et al.
MOLECULAR CELL (2020)
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
Gabriela M. Escalante et al.
VACCINES (2020)
CryoEM structure of the tegumented capsid of Epstein-Barr virus
Zhihai Li et al.
CELL RESEARCH (2020)
Therapeutic nanovaccines sensitize EBV-associated tumors to checkpoint blockade therapy
Hong Liu et al.
BIOMATERIALS (2020)
Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus
Swati Singh et al.
CELL REPORTS MEDICINE (2020)
EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
Shaofen Huo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
Xiao Zhang et al.
THERANOSTICS (2020)
Epstein-Barr virus strain variation and cancer
Teru Kanda et al.
CANCER SCIENCE (2019)
Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
Wei Bu et al.
IMMUNITY (2019)
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis
Christian Muenz
NATURE REVIEWS MICROBIOLOGY (2019)
The Global Landscape of EBV-Associated Tumors
Claire Shannon-Lowe et al.
FRONTIERS IN ONCOLOGY (2019)
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4-and CD8-restricted epitopes as targets for T-cell immunotherapy
Mamta Kalra et al.
CYTOTHERAPY (2019)
Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation
Yan Chen et al.
PLOS PATHOGENS (2019)
Hemophagocytic Lymphohistiocytosis
Hanny Al-Samkari et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
Joost Snijder et al.
IMMUNITY (2018)
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Primary Epstein-Barr virus infection
Samantha K. Dunmire et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames
Maja Bencun et al.
NUCLEIC ACIDS RESEARCH (2018)
Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture
Jerome E. Tanner et al.
CANCERS (2018)
EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
Joanna B. Wilson et al.
CANCERS (2018)
Epstein–Barr Virus and Cancer
Paul J. Farrell
Annual Review of Pathology-Mechanisms of Disease (2018)
Non-Human Primate Models of Enteric Viral Infections
Karol Sestak
VIRUSES-BASEL (2018)
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
Dwain G. van Zyl et al.
PLOS PATHOGENS (2018)
Immunotherapy against cancer-related viruses
Haruko Tashiro et al.
CELL RESEARCH (2017)
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
Hassan Abolhassani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman et al.
IMMUNOLOGICAL REVIEWS (2017)
Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen-Containing Particles
Maria Lopez-Montanes et al.
JOURNAL OF IMMUNOLOGY (2017)
Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children
Carrie B. Coleman et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes
Christian Munz
FRONTIERS IN IMMUNOLOGY (2017)
Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent
Xiaoyun Lin et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth
Ka-Won Noh et al.
BMB REPORTS (2016)
The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
Yongfeng Si et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2016)
Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV
Wei Bu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Viral vectors as vaccine platforms: from immunogenicity to impact
Katie J. Ewer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Cognate HLA absence in trans diminishes human NK cell education
Vanessa Landtwing et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis
Maarten van Wijhe et al.
LANCET INFECTIOUS DISEASES (2016)
Childhood Vaccination Implications for Global and Domestic Public Health
David S. Younger et al.
NEUROLOGIC CLINICS (2016)
Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits
Darren S. Heeke et al.
VACCINE (2016)
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
Xinle Cui et al.
VACCINE (2016)
Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins
Karthik Sathiyamoorthy et al.
NATURE COMMUNICATIONS (2016)
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
Jill M. Brooks et al.
PLOS PATHOGENS (2016)
CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
Ferdy R. van Diemen et al.
PLOS PATHOGENS (2016)
Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study
Kristin H. Johnson et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Prospective studies of infectious mononucleosis in university students
Jennifer M. Grimm et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
The immunology of Epstein-Barr Virus Induced Disease
Graham S. Taylor et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Masaru Kanekiyo et al.
CELL (2015)
Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation
Archana Panikkar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
Javier Gordon Ogembo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction
Archana Panikkar et al.
JOURNAL OF VIROLOGY (2015)
Peptides Designed To Spatially Depict the Epstein-Barr Virus Major Virion Glycoprotein gp350 Neutralization Epitope Elicit Antibodies That Block Virus-Neutralizing Antibody 72A1 Interaction with the Native gp350 Molecule
Jerome E. Tanner et al.
JOURNAL OF VIROLOGY (2015)
Valganciclovir Administration to Kidney Donors to Reduce the Burden of Cytomegalovirus and Epstein-Barr Virus Transmission During Transplantation
Priya S. Verghese et al.
TRANSPLANTATION (2015)
Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo
Esteban Servat et al.
VACCINE (2015)
The Evolution of Poxvirus Vaccines
Lucas Sanchez-Sampedro et al.
VIRUSES-BASEL (2015)
The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events
Samantha K. Dunmire et al.
PLOS PATHOGENS (2015)
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development
Alex S. Hartlage et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines
Carrie B. Coleman et al.
JOURNAL OF VIROLOGY (2015)
B cell-derived circulating granzyme B is a feature of acute infectious mononucleosis
Magdalena Hagn et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Role for early-differentiated natural killer cells in infectious mononucleosis
Tarik Azzi et al.
BLOOD (2014)
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
Graham S. Taylor et al.
CLINICAL CANCER RESEARCH (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity
Minhtran Charlotte Ngo et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Adenovirus-Based Vaccines against Rhesus Lymphocryptovirus EBNA-1 Induce Expansion of Specific CD8+ and CD4+ T Cells in Persistently Infected Rhesus Macaques
R. Leskowitz et al.
JOURNAL OF VIROLOGY (2014)
Regulation of Epstein-Barr virus reactivation from latency
Takayuki Murata
MICROBIOLOGY AND IMMUNOLOGY (2014)
Epstein-Barr Virus Turns 50
Paul M. Lieberman
SCIENCE (2014)
Progress, prospects, and problems in Epstein-Barr virus vaccine development
Henry H. Balfour
CURRENT OPINION IN VIROLOGY (2014)
Assembly and Architecture of the EBV B Cell Entry Triggering Complex
Karthik Sathiyamoorthy et al.
PLOS PATHOGENS (2014)
Human B cell-derivec ymphoblastoid cell I nes constitutively produce Fas ligand and secrete MHCII+FasL+ killer exosomes
Matthew W. Klinker et al.
FRONTIERS IN IMMUNOLOGY (2014)
Expression, purification, and immunogenic characterization of Epstein-Barr virus recombinant EBNA1 protein in Pichia pastoris
Man Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
Edwin P. Hui et al.
CANCER RESEARCH (2013)
CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response
Rachel J. M. Abbott et al.
JOURNAL OF IMMUNOLOGY (2013)
Delayed-type Hypersensitivity (DTH) Immune Response Related With EBV-DNA in Nasopharyngeal Carcinoma Treated With Autologous Dendritic Cell Vaccination After Radiotherapy
Feng Li et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein-Barr Virus Infection in University Students
Henry H. Balfour et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy
Manish Patel et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA
Sophia Pavlova et al.
JOURNAL OF VIROLOGY (2013)
Therapeutic Vaccination against the Rhesus Lymphocryptovirus EBNA-1 Homologue, rhEBNA-1, Elicits T Cell Responses to Novel Epitopes in Rhesus Macaques
Eduardo L. V. Silveira et al.
JOURNAL OF VIROLOGY (2013)
CD4+ and CD8+ T-Cell Responses to Latent Antigen EBNA-1 and Lytic Antigen BZLF-1 during Persistent Lymphocryptovirus Infection of Rhesus Macaques
R. M. Leskowitz et al.
JOURNAL OF VIROLOGY (2013)
Keeping it quiet: chromatin control of gammaherpesvirus latency
Paul M. Lieberman
NATURE REVIEWS MICROBIOLOGY (2013)
A novel tetrameric gp3501-470 as a potential Epstein-Barr virus vaccine
Xinle Cui et al.
VACCINE (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Javier G. Ogembo et al.
CELL REPORTS (2013)
Immune response of mice to a latency membrane protein 2 multiepitope antigen of Epstein-Barr virus applied as DNA vaccine and/or peptide vaccine
W. Li et al.
ACTA VIROLOGICA (2013)
A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
W. K. Chia et al.
ANNALS OF ONCOLOGY (2012)
Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
Corey Smith et al.
CANCER RESEARCH (2012)
The initiation and prevention of multiple sclerosis
Alberto Ascherio et al.
NATURE REVIEWS NEUROLOGY (2012)
Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children
Helen Trottier et al.
TRANSFUSION (2012)
Understanding human T-cell-mediated immunoregulation through herpesviruses
Scott R. Burrows et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Fusion of Epstein-Barr Virus with Epithelial Cells Can Be Triggered by αvβ5 in Addition to αvβ6 and αvβ8, and Integrin Binding Triggers a Conformational Change in Glycoproteins gHgL
Liudmila S. Chesnokova et al.
JOURNAL OF VIROLOGY (2011)
A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
Romana Ruiss et al.
JOURNAL OF VIROLOGY (2011)
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
Steven Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combination
Zhan Wang et al.
SCIENCE CHINA-LIFE SCIENCES (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Reconstituted complexes of mycobacterial HSP70 and EBV LMP2A-derived peptides elicit peptide-specific cytotoxic T lymphocyte responses and anti-tumor immunity
Genyan Liu et al.
VACCINE (2011)
Viruses - from pathogens to vaccine carriers
Juliana C. Small et al.
CURRENT OPINION IN VIROLOGY (2011)
Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge
Junji Sashihara et al.
PLOS PATHOGENS (2011)
Recognition of herpesviruses by the innate immune system
Soren R. Paludan et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Epstein-Barr virus and gastric carcinoma
Masashi Fukayama
PATHOLOGY INTERNATIONAL (2010)
A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children
L. M. Butler et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Lifelong persistent EBV infection of rabbits with EBER1-positive lymphocyte infiltration and mild sublethal hemophagocytosis
Kyosuke Kanai et al.
VIRUS RESEARCH (2010)
Immunotherapy of Epstein-Barr Virus Associated Malignancies Using Mycobacterial HSP70 and LMP2A356-364 Epitope Fusion Protein
Genyan Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Recombinant adeno-associated virus encoding Epstein-Barr virus latent membrane proteins fused with heat shock protein as a potential vaccine for nasopharyngeal carcinoma
Jianqing Pan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells
Sabyasachi Halder et al.
PLOS ONE (2009)
A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
Lesley Rees et al.
TRANSPLANTATION (2009)
EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells
Jianqiao Xiao et al.
VIROLOGY (2009)
Epstein-Barr virus in autoimmune diseases
Eric Toussirot et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Risk of herpes zoster in adults immunized with varicella vaccine
Sophie Hambleton et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A new animal model for primary and persistent Epstein-Barr virus infection: Human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis
Kazuaki Takashima et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Unique structures in a tumor herpesvirus revealed by cryo-electron tomography and microscopy
Wei Dai et al.
JOURNAL OF STRUCTURAL BIOLOGY (2008)
Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles
Marisa Granato et al.
JOURNAL OF VIROLOGY (2008)
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles
Dinesh Adhikary et al.
JOURNAL OF VIROLOGY (2008)
Phase I trial of a CD8+ T-Cell peptide epitope-based vaccine for infectious mononucleosis
Suzanne L. Elliott et al.
JOURNAL OF VIROLOGY (2008)
Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
Etienne M. Sokal et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)
Kendra A. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults
Michel Moutschen et al.
VACCINE (2007)
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naive and vaccinia-immune individuals
Janie Parrino et al.
VACCINE (2007)
The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing
Isabel Y. Pappworth et al.
JOURNAL OF VIROLOGY (2007)
Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells
Susan M. Turk et al.
JOURNAL OF VIROLOGY (2006)
A cohort study among University students: Identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis
DH Crawford et al.
CLINICAL INFECTIOUS DISEASES (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Genetic design of an optimized packaging cell line for gene vectors transducing human B cells
E Hettich et al.
GENE THERAPY (2006)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses
Florian Bihl et al.
JOURNAL OF IMMUNOLOGY (2006)
Adverse events associated with smallpox vaccination in the United States, January-October 2003
CG Casey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Differential targeting and shifts in the immunodominance of Epstein-Barr virus-specific CD8 and CD4 T cell responses during acute and persistent infection
T Woodberry et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLFI) prevents reactivation of EBV from latency
C Schelcher et al.
JOURNAL OF VIROLOGY (2005)
Defective infectious particles and rare packaged Genomes produced by cells carrying terminal-repeat-negative Epstein-Barr virus
R Feederle et al.
JOURNAL OF VIROLOGY (2005)
The immune response to primary EBV infection: a role for natural killer cells
H Williams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Development of a human adaptive immune system in cord blood cell-transplanted mice
E Traggiai et al.
SCIENCE (2004)
Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells
Y Isobe et al.
CANCER RESEARCH (2004)
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host
P Rivailler et al.
BLOOD (2004)
Proteins of purified Epstein-Barr virus
E Johannsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Three-dimensional structure of herpes simplex virus from cryo-electron tomography
K Grünewald et al.
SCIENCE (2003)
B cells under influence:: Transformation of B cells by Epstein-Barr virus
R Küppers
NATURE REVIEWS IMMUNOLOGY (2003)
Characterization of the CD4+T cell response Epstein-Barr virus during primary and persistent infection
E Amyes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Multiple Epstein-Barr virus infections in healthy individuals
DM Walling et al.
JOURNAL OF VIROLOGY (2003)
Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma
J Duraiswamy et al.
BLOOD (2003)
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
SM Tugizov et al.
NATURE MEDICINE (2003)
Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection
ML Precopio et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunological aspects of Epstein-Barr virus infection
S Ohga et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design
M Bharadwaj et al.
VACCINE (2001)
Share Paper
